Found 210 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2016
N. le Roex, Cooper, D., van Helden, P. D., Hoal, E. G., and Jolles, A. E., “Disease Control in Wildlife: Evaluating a Test and Cull Programme for Bovine Tuberculosis in African Buffalo.”, Transbound Emerg Dis, vol. 63, no. 6, pp. 647-657, 2016.
M. L. Galbraith, Vorachek, W. R., Estill, C. T., Whanger, P. D., Bobe, G., Davis, T. Z., and Hall, J. A., “Rumen Microorganisms Decrease Bioavailability of Inorganic Selenium Supplements.”, Biol Trace Elem Res, vol. 171, no. 2, pp. 338-343, 2016.
S. J. Valberg, McKenzie, E. C., Eyrich, L. V., Shivers, J., Barnes, N. E., and Finno, C. J., “Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis.”, Equine Vet J, vol. 48, no. 5, pp. 548-56, 2016.
2017
J. Fowler, Stieger-Vanegas, S. M., Vanegas, J. A., Bobe, G., and Poulsen, K. P., “Comparison of Thoracic Radiography and Computed Tomography in Calves with Naturally Occurring Respiratory Disease.”, Front Vet Sci, vol. 4, p. 101, 2017.
C. K. Glidden, Beechler, B. R., Buss, P. Erik, Charleston, B., de Klerk-Lorist, L. - M., Maree, F. Frederick, Muller, T., Perez-Martin, E., Scott, K. Anne, van Schalkwyk, O. Louis, and Jolles, A. E., “Detection of Pathogen Exposure in African Buffalo Using Non-Specific Markers of Inflammation.”, Front Immunol, vol. 8, p. 1944, 2017.
L. G. Wallace, Bobe, G., Vorachek, W. R., Dolan, B. P., Estill, C. T., Pirelli, G. J., and Hall, J. A., “Effects of feeding pregnant beef cows selenium-enriched alfalfa hay on selenium status and antibody titers in their newborn calves.”, J Anim Sci, vol. 95, no. 6, pp. 2408-2420, 2017.
B. R. Beechler, Jolles, A. E., Budischak, S. A., Corstjens, P. L. A. M., Ezenwa, V. O., Smith, M., Spaan, R. S., van Dam, G. J., and Steinauer, M. L., “Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population.”, PLoS Negl Trop Dis, vol. 11, no. 12, p. e0006122, 2017.
K. Rahman, Vengrenyuk, Y., Ramsey, S. A., Vila, N. Rotllan, Girgis, N. M., Liu, J., Gusarova, V., Gromada, J., Weinstock, A., Moore, K. J., Loke, P. 'ng, and Fisher, E. A., “Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.”, J Clin Invest, vol. 127, no. 8, pp. 2904-2915, 2017.
K. Rahman, Vengrenyuk, Y., Ramsey, S. A., Vila, N. Rotllan, Girgis, N. M., Liu, J., Gusarova, V., Gromada, J., Weinstock, A., Moore, K. J., Loke, P. 'ng, and Fisher, E. A., “Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.”, J Clin Invest, vol. 127, no. 8, pp. 2904-2915, 2017.
D. Vyshenska, Lam, K. C., Shulzhenko, N., and Morgun, A., “Interplay between viruses and bacterial microbiota in cancer development.”, Semin Immunol, vol. 32, pp. 14-24, 2017.
H. Leeper, Viall, A., Ruaux, C., and Bracha, S., “Preliminary evaluation of serum total cholesterol concentrations in dogs with osteosarcoma.”, J Small Anim Pract, vol. 58, no. 10, pp. 562-569, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
D. Roymans, Alnajjar, S. S., Battles, M. B., Sitthicharoenchai, P., Furmanova-Hollenstein, P., Rigaux, P., Van den Berg, J., Kwanten, L., Van Ginderen, M., Verheyen, N., Vranckx, L., Jaensch, S., Arnoult, E., Voorzaat, R., Gallup, J. M., Larios-Mora, A., Crabbe, M., Huntjens, D., Raboisson, P., Langedijk, J. P., Ackermann, M. R., McLellan, J. S., Vendeville, S., and Koul, A., “Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.”, Nat Commun, vol. 8, no. 1, p. 167, 2017.
N. le Roex, Jolles, A. E., Beechler, B. R., van Helden, P., and Hoal, E., “Toll-like receptor (TLR) diversity influences mycobacterial growth in African buffalo.”, Tuberculosis (Edinb), vol. 104, pp. 87-94, 2017.
2018
M. Bodogai, O'Connell, J., Kim, K., Kim, Y., Moritoh, K., Chen, C., Gusev, F., Vaughan, K., Shulzhenko, N., Mattison, J. A., Lee-Chang, C., Chen, W., Carlson, O., Becker, K. G., Gurung, M., Morgun, A., White, J., Meade, T., Perdue, K., Mack, M., Ferrucci, L., Trinchieri, G., de Cabo, R., Rogaev, E., Egan, J., Wu, J., and Biragyn, A., “Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells.”, Sci Transl Med, vol. 10, no. 467, 2018.
J. A. Hall, Jackson, M. I., Vondran, J. C., Vanchina, M. A., and Jewell, D. E., “Comparison of circulating metabolite concentrations in dogs and cats when allowed to freely choose macronutrient intake.”, Biol Open, vol. 7, no. 11, 2018.
J. A. Hall, Jackson, M. I., Vondran, J. C., Vanchina, M. A., and Jewell, D. E., “Comparison of circulating metabolite concentrations in dogs and cats when allowed to freely choose macronutrient intake.”, Biol Open, vol. 7, no. 11, 2018.
H. F. Tavalire, Beechler, B. R., Buss, P. E., Gorsich, E. E., Hoal, E. G., le Roex, N., Spaan, J. M., Spaan, R. S., van Helden, P. D., Ezenwa, V. O., and Jolles, A. E., “Context-dependent costs and benefits of tuberculosis resistance traits in a wild mammalian host.”, Ecol Evol, vol. 8, no. 24, pp. 12712-12726, 2018.
N. Shulzhenko, Dong, X., Vyshenska, D., Greer, R. L., Gurung, M., Vasquez-Perez, S., Peremyslova, E., Sosnovtsev, S., Quezado, M., Yao, M., Montgomery-Recht, K., Strober, W., Fuss, I. J., and Morgun, A., “CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.”, Clin Immunol, vol. 197, pp. 139-153, 2018.
N. Shulzhenko, Dong, X., Vyshenska, D., Greer, R. L., Gurung, M., Vasquez-Perez, S., Peremyslova, E., Sosnovtsev, S., Quezado, M., Yao, M., Montgomery-Recht, K., Strober, W., Fuss, I. J., and Morgun, A., “CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.”, Clin Immunol, vol. 197, pp. 139-153, 2018.
A. Larios Mora, Detalle, L., Gallup, J. M., Van Geelen, A., Stohr, T., Duprez, L., and Ackermann, M. R., “Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs.”, MAbs, vol. 10, no. 5, pp. 778-795, 2018.

Pages